AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain ingredients
| Active ingredient | Strength |
|---|---|
| Antihemophilic factor, human recombinant | see label |
What AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is used for
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
- Generic name
- Antihemophilic factor, human recombinant
- Made by
- CSL Behring Lengnau AG
- Forms
- Kit
- FDA approval
- Biologic licence (BLA) BLA125591
- On the US market since
- 2016
Official information
- MedlinePlus drug information (search for Antihemophilic factor, human recombinant)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is AFSTYLA Antihemophilic Factor (Recombinant), Single Chain?
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain (Antihemophilic factor, human recombinant) is a specialist medicine made by CSL Behring Lengnau AG, approved by the US FDA.
What are the ingredients of AFSTYLA Antihemophilic Factor (Recombinant), Single Chain?
AFSTYLA Antihemophilic Factor (Recombinant), Single Chain contains Antihemophilic factor, human recombinant.
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA